Toshihisa Ishikawa
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms 92
- Biochemistry top 0.2%
- Sulfur Compounds in Biology 14
- Amino Acid Enzymes and Metabolism 12
- Pharmacology top 0.2%
-
- Pharmacological Effects and Toxicity Studies 20
- Nutrition and Dietetics top 1%
-
- HIV/AIDS drug development and treatment 28
-
- Cancer therapeutics and mechanisms 15
- RNA Interference and Gene Delivery 10
-
- Cholesterol and Lipid Metabolism 13
- Co-authors
- Francis Ali‐OsmanHelmut SiesHiroshi NakagawaAi TamuraM. Tien KuoDietrich KepplerYoji IkegamiNiramol Savaraj
- Cited by
- OncologyBiochemistryPharmacology
- Journals
- Journal of the American Chemical Society (1 paper)Journal of Biological Chemistry (10 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Toshihisa Ishikawa
156 papers receiving 7.5k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 4.4k
- Biochemistry 833
- Pharmacology 734
- Pediatrics, Perinatology and Child Health 1.5k
- Nutrition and Dietetics 870
Countries citing papers authored by Toshihisa Ishikawa
This map shows the geographic impact of Toshihisa Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihisa Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihisa Ishikawa more than expected).
Fields of papers citing papers by Toshihisa Ishikawa
This network shows the impact of papers produced by Toshihisa Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihisa Ishikawa. The network helps show where Toshihisa Ishikawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toshihisa Ishikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 4 | |
| 2 | 2017 | 19 | |
| 3 | 2016 | 17 | |
| 4 | 2011 | 7 | |
| 5 | 2009 | 26 | |
| 6 | 2008 | 120 | |
| 7 | Theoretical studies for molecular modeling of new camptothecin analogues | 2007 | 2 |
| 8 | 2007 | 241 | |
| 9 | 2005 | 32 | |
| 10 | [Drug resistance mediated by ABC transporters]. | 2004 | 3 |
| 11 | Human ATP-binding cassette transporter ABCC10: expression profile and p53-dependent upregulation. | 2004 | 34 |
| 12 | 2002 | 23 | |
| 13 | 2002 | 10 | |
| 14 | 2001 | 161 | |
| 15 | 2000 | 203 | |
| 16 | 2000 | 15 | |
| 17 | 1998 | 8 | |
| 18 | 1997 | 109 | |
| 19 | Transient induction of the MRP/GS-X pump and gamma-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea in human glioma cells. | 1997 | 43 |
| 20 | 1987 | 1 |
About Toshihisa Ishikawa
Toshihisa Ishikawa is a scholar working on Biochemistry, Oncology and Infectious Diseases, having authored 156 papers that have together received 7.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (92 papers), HIV/AIDS drug development and treatment (28 papers), Pharmacological Effects and Toxicity Studies (20 papers), Cancer therapeutics and mechanisms (15 papers), Sulfur Compounds in Biology (14 papers), Cholesterol and Lipid Metabolism (13 papers), Amino Acid Enzymes and Metabolism (12 papers) and RNA Interference and Gene Delivery (10 papers). The work is most often cited by research in Oncology (4.4k citations), Biochemistry (833 citations) and Pharmacology (734 citations). Toshihisa Ishikawa has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Francis Ali‐Osman, Helmut Sies, Hiroshi Nakagawa, Ai Tamura, M. Tien Kuo, Dietrich Keppler, Yoji Ikegami, Niramol Savaraj, Yu Toyoda and Thomas P. Schaub. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.